EQS-News 101 0 Kommentare Heidelberg Pharma to Participate and Present at Upcoming Leading Scientific Conferences in May and June 2024

Für Sie zusammengefasst

Heidelberg Pharma to present at scientific conferences in May and June 2024.
Lead ADC product HDP-101 targeting multiple myeloma shows promise.
Company developing innovative ADCs for effective cancer treatment.

EQS-News: Heidelberg Pharma AG / Key word(s): Conference
Heidelberg Pharma to Participate and Present at Upcoming Leading Scientific Conferences in May and June 2024

23.05.2024 / 09:12 CET/CEST
The issuer is solely responsible for the content of this announcement.

PRESS RELEASE

Heidelberg Pharma to Participate and Present at Upcoming Leading Scientific Conferences in May and June 2024

Ladenburg, Germany, 23 May 2024 – Heidelberg Pharma AG (FSE: HPHA), a clinical stage biotech company developing innovative Antibody Drug Conjugates (ADCs), is pleased to announce that its management team will be participating and presenting on its proprietary ADC technology platforms at the following scientific conferences in May and June in 2024.

Heidelberg Pharma is an ADC specialist, developing innovative drugs based on its proprietary ADC toolbox for the targeted and highly effective treatment of cancer. Its lead Amanitin-based ADC product candidate, HDP-101, targeting relapsed or refractory multiple myeloma has recently received Orphan Drug Designation (ODD) and is currently advancing in a Phase I/IIa clinical trial, demonstrating first signs of clinical efficacy. The Company is also rapidly expanding its therapeutic product pipeline with a further four programs across a variety of malignant hematologic and solid tumors.

10^th Annual Oncology Innovation Forum
Date & location: 31 May 2024, Chicago, Illinois, USA
Panel: Investing in NextGen ADCs
Date: 31 May, 10:45 am CDT
Panellist: Professor Andreas Pahl, Chief Executive Officer

Presentation title: Company presentation
Date: 31 May, 02:00 pm CDT
Presenter: Professor Andreas Pahl, Chief Executive Officer

Professor Pahl will be available for one-on-one meetings, which can be arranged via the online conference system.

ASCO Annual Meeting
Date & location: 31 May–4 June 2024, Chicago, Illinois, USA
Attending: Professor Andreas Pahl, Chief Executive Officer & Dr. András Strassz, Chief Medical Officer

Professor Pahl and Dr. Strassz will be available for meetings.

BIO International Convention

Seite 1 von 4

Seite 2 ►